本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Syros Pharmaceuticals, Inc.

0.0300
-0.0008-2.60%
成交量:14.94万
成交额:4,203.13
市值:80.50万
市盈率:-0.01
高:0.0300
开:0.0268
低:0.0257
收:0.0308
数据加载中...
2024/11/13

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/10/31

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/09/05

重要事件披露

Form 8-K - Current report
2024/08/12

重要事件披露

Form 8-K - Current report
2024/08/02

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/07/31

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/07/31

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/06/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/06

重要事件披露

Form 8-K - Current report
2024/05/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/27

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/27

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/09

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/07

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]